1. Home
  2. BOLD vs SWIN Comparison

BOLD vs SWIN Comparison

Compare BOLD & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • SWIN
  • Stock Information
  • Founded
  • BOLD 2018
  • SWIN 2017
  • Country
  • BOLD United States
  • SWIN Hong Kong
  • Employees
  • BOLD N/A
  • SWIN N/A
  • Industry
  • BOLD
  • SWIN
  • Sector
  • BOLD
  • SWIN
  • Exchange
  • BOLD Nasdaq
  • SWIN Nasdaq
  • Market Cap
  • BOLD 81.0M
  • SWIN 33.6M
  • IPO Year
  • BOLD 2024
  • SWIN 2023
  • Fundamental
  • Price
  • BOLD $3.15
  • SWIN $2.41
  • Analyst Decision
  • BOLD Strong Buy
  • SWIN
  • Analyst Count
  • BOLD 3
  • SWIN 0
  • Target Price
  • BOLD $23.00
  • SWIN N/A
  • AVG Volume (30 Days)
  • BOLD 46.2K
  • SWIN 272.7K
  • Earning Date
  • BOLD 08-12-2024
  • SWIN 09-17-2024
  • Dividend Yield
  • BOLD N/A
  • SWIN N/A
  • EPS Growth
  • BOLD N/A
  • SWIN N/A
  • EPS
  • BOLD N/A
  • SWIN N/A
  • Revenue
  • BOLD N/A
  • SWIN $3,437,000.00
  • Revenue This Year
  • BOLD N/A
  • SWIN N/A
  • Revenue Next Year
  • BOLD N/A
  • SWIN N/A
  • P/E Ratio
  • BOLD N/A
  • SWIN N/A
  • Revenue Growth
  • BOLD N/A
  • SWIN N/A
  • 52 Week Low
  • BOLD $2.85
  • SWIN $1.84
  • 52 Week High
  • BOLD $15.24
  • SWIN $72.55
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • SWIN 39.74
  • Support Level
  • BOLD N/A
  • SWIN $2.36
  • Resistance Level
  • BOLD N/A
  • SWIN $2.65
  • Average True Range (ATR)
  • BOLD 0.00
  • SWIN 0.24
  • MACD
  • BOLD 0.00
  • SWIN 0.04
  • Stochastic Oscillator
  • BOLD 0.00
  • SWIN 8.47

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About SWIN Solowin Holdings

Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its advanced and secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derive4s maximum revenue from investment advisory services.

Share on Social Networks: